Patents by Inventor Peter Stephenson

Peter Stephenson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10971256
    Abstract: A computerized system comprising a social robot for interacting with a patient in order to improve the patient's adherence to a health or medical regime. A patient is instructed to perform a health activity (e.g., take medication, step on scale, measure glucose, play a game) at certain intervals in order to reach a specified goal or expected result. The results of the health activity are recorded in a wireless health device and transmitted to a computer. The computer interprets the result of health activity and communicates an action to the robot. If the patient performs the activity within a specified interval and results are consistent with the specified goal or expected result, the robot communicates a positive reaction. If the patient does not perform the activity within a specified interval, or if the results are not consistent with the specified goal or expected result, the robot communicates a negative reaction.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: April 6, 2021
    Assignee: Humana Inc.
    Inventor: Peter Stephenson
  • Publication number: 20190122319
    Abstract: A computerized system comprising a social robot for interacting with a patient in order to improve the patient's adherence to a health or medical regime. A patient is instructed to perform a health activity (e.g., take medication, step on scale, measure glucose, play a game) at certain intervals in order to reach a specified goal or expected result. The results of the health activity are recorded in a wireless health device and transmitted to a computer. The computer interprets the result of health activity and communicates an action to the robot. If the patient performs the activity within a specified interval and results are consistent with the specified goal or expected result, the robot communicates a positive reaction. If the patient does not perform the activity within a specified interval, or if the results are not consistent with the specified goal or expected result, the robot communicates a negative reaction.
    Type: Application
    Filed: December 20, 2018
    Publication date: April 25, 2019
    Inventor: Peter Stephenson
  • Patent number: 10163175
    Abstract: A computerized system comprising a social robot for interacting with a patient in order to improve the patient's adherence to a health or medical regime. A patient is instructed to perform a health activity (e.g., take medication, step on scale, measure glucose, play a game) at certain intervals in order to reach a specified goal or expected result. The results of the health activity are recorded in a wireless health device and transmitted to a computer. The computer interprets the result of health activity and communicates an action to the robot. If the patient performs the activity within a specified interval and results are consistent with the specified goal or expected result, the robot communicates relief or pleasure. If the patient does not perform the activity within a specified interval, or if the results are not consistent with the specified goal or expected result, the robot communicates anxiety, disappointment or exhibits symptoms of an effect such as hunger or illness.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: December 25, 2018
    Assignee: Humana Inc.
    Inventor: Peter Stephenson
  • Publication number: 20160358276
    Abstract: A computerized system comprising a social robot for interacting with a patient in order to improve the patient's adherence to a health or medical regime. A patient is instructed to perform a health activity (e.g., take medication, step on scale, measure glucose, play a game) at certain intervals in order to reach a specified goal or expected result. The results of the health activity are recorded in a wireless health device and transmitted to a computer. The computer interprets the result of health activity and communicates an action to the robot. If the patient performs the activity within a specified interval and results are consistent with the specified goal or expected result, the robot communicates relief or pleasure. If the patient does not perform the activity within a specified interval, or if the results are not consistent with the specified goal or expected result, the robot communicates anxiety, disappointment or exhibits symptoms of an effect such as hunger or illness.
    Type: Application
    Filed: February 24, 2010
    Publication date: December 8, 2016
    Applicant: Humana Inc.
    Inventor: Peter Stephenson
  • Publication number: 20160232303
    Abstract: A system for responding to natural-language inquiries is described. The system accesses a textual natural language inquiry originated by a user. For each of one or more inquiry attributes, the system extracts from the textual natural language query a value for the inquiry attribute. The system uses the extracted inquiry attribute values to construct one or more HIPAA requests seeking information relevant to the inquiry. The system submits the constructed requests to a payer computer system. In response to submission of the constructed requests, the system receives from a payer computer system one or more HIPAA responses. Using information contained by at least one of the received HIPAA responses, the system generates a textual natural language response.
    Type: Application
    Filed: February 5, 2016
    Publication date: August 11, 2016
    Inventors: Ronen Amit, Jan Jungclaus, Peter Stephenson
  • Publication number: 20080082380
    Abstract: A method for evaluating a system having at least one portal is provided, wherein the method includes examining the at least one portal to identify at least one accessible portal, performing a qualitative analysis responsive to the at least one accessible portal, performing a quantitative analysis responsive to the qualitative analysis and generating a risk profile responsive to the performing a qualitative analysis and the performing a quantitative analysis.
    Type: Application
    Filed: May 19, 2007
    Publication date: April 3, 2008
    Inventor: Peter Stephenson
  • Publication number: 20070185157
    Abstract: The present invention provides compounds of formula (I) wherein X, Y, R1, R2 and R3 are as defined hereinabove. The compounds of the present invention are modulators, especially antagonists, of the activity of chemokine CCR5 receptors. Modulators of the CCR5 receptor may be useful in the treatment of various inflammatory diseases and conditions, and in the treatment of infection by HIV and genetically related retroviruses.
    Type: Application
    Filed: April 4, 2007
    Publication date: August 9, 2007
    Inventors: Patricia Basford, Peter Stephenson, Stefan Taylor, Anthony Wood
  • Publication number: 20070027115
    Abstract: The invention provides compounds of formula I, R1—OP(O)(OH)2??I wherein R1 represents the non-hydroxy portion of a triazole antifungal compound of the type comprising a tertiary hydroxy group; or a pharmaceutically acceptable salt thereof. The compounds of the invention are useful in the treatment of fungal infections, and have good aqueous solubility.
    Type: Application
    Filed: September 29, 2006
    Publication date: February 1, 2007
    Inventors: Stuart Green, Peter Stephenson, Charles Murtiashaw, Martha Murtiashaw
  • Publication number: 20050130940
    Abstract: The invention provides compounds of formula I, R1—OP(O)(OH)2??I wherein R1 represents the non-hydroxy portion of a triazole antifungal compound of the type comprising a tertiary hydroxy group; or a pharmaceutically acceptable salt thereof. The compounds of the invention are useful in the treatment of fungal infections, and have good aqueous solubility.
    Type: Application
    Filed: January 28, 2005
    Publication date: June 16, 2005
    Inventors: Stuart Green, Peter Stephenson, Charles Murtiashaw
  • Publication number: 20050116951
    Abstract: Line drawing techniques that employ runs or runs of runs of pixels to draw the line compute line structure information that they use to determine the sequence of runs in the line. This line structure information may be used to compute the positions of a plurality of the runs and then draw the runs in parallel. The line drawing techniques may be also be used with rays in three dimensions. Projections of the ray are made on planes that intersect each other on the ray's major axis. The line drawing techniques are used to determine cells in the planes that are intersected by the projections. The voxels intersected by the ray are then determined using the cells. Runs of voxels in the ray are used in ray traversals. The volume traversed by the ray is subdivided into encoding runs of voxels that may include one or more significant runs containing voxels whose data will affect the ray.
    Type: Application
    Filed: January 6, 2003
    Publication date: June 2, 2005
    Inventor: Peter Stephenson
  • Publication number: 20050107424
    Abstract: The present invention provides compounds of formula (I) wherein X, Y, R1, R2 and R3 are as defined hereinabove. The compounds of the present invention are modulators, especially antagonists, of the activity of chemokine CCR5 receptors. Modulators of the CCR5 receptor may be useful in the treatment of various inflammatory diseases and conditions, and in the treatment of infection by HIV and genetically related retroviruses.
    Type: Application
    Filed: December 15, 2004
    Publication date: May 19, 2005
    Inventors: Patricia Basford, Peter Stephenson, Stefan Taylor, Anthony Wood
  • Publication number: 20050043300
    Abstract: This invention relates to a compound of formula (I) or pharmaceutically acceptable salts, solvates or derivatives thereof, wherein R1 to R5 are defined in the description, and to processes for the preparation thereof, intermediates used in their preparation, compositions containing them and the uses of such derivatives. The compounds of the present invention inhibit the interaction of gp120 with CD4 and are therefore of use in the treatment of HIV, a retroviral infection genetically related to HIV, or AIDS.
    Type: Application
    Filed: August 3, 2004
    Publication date: February 24, 2005
    Inventors: Donald Middleton, Charles Mowbray, Peter Stephenson, David Williams
  • Publication number: 20050001840
    Abstract: Line drawing techniques that employ runs or runs of runs of pixels to draw the line compute line structure information that they use to determine the sequence of runs in the line. This line structure information may be used in other ways to enhance the line drawing operation. One of the ways is to use the line structure information to compute the positions of a plurality of the runs and then draw the runs in parallel. Another way is to use the line structure information to determine properties of sets of cells that include not only cells of the run, but additional cells that are affected by the presence of the cells of the run. One example of such sets of cells is the cells of the run plus anti-aliasing cells. The line structure information can be used to determine the location and size of a set of cells and the intensities of the anti-aliasing cells. Another example of such sets of cells are cells that are written together in a single memory operation.
    Type: Application
    Filed: December 12, 2002
    Publication date: January 6, 2005
    Inventors: Peter Stephenson, Bruce Litow, Nicholas Diakopoulos
  • Publication number: 20040189641
    Abstract: Disclosed are techniques for determining in a lattice a set of cells of the lattice that are intersected by a line endpoints. The tech-niques employ orders 1 . . . n of runs of lattice cells to make the determination and are usable with lines whose endpoints have coordinates that may be any real number. The techniques include an initialization that derives an error term with a real number value and a structural parameter with a real number value for order 1 using the values of the coordinates of the end points and then determines the error terms and structural parameters for each order i belonging to the orders 2 . . . n using the error term and structural parameter for order i−1. When the first run of any orders 1 . . . n is truncated, the initialization also adds the cells belonging to the truncated run to the set. When the initialization is finished, the remaining cells belonging to the set are determined using full runs of order n.
    Type: Application
    Filed: February 2, 2004
    Publication date: September 30, 2004
    Inventors: Peter Stephenson, Bruce Litow
  • Patent number: 6332865
    Abstract: A self-advancing endoscope (10) comprising an elongated flexible tubular member (12) and an elongated channel (14) defined by the tubular member (12) and having a distal end wall (16). Piston means (22) are slideably disposed in the channel (14) toward the distal end wall (16). The endoscope (10) also comprises means (24, 26) for reciprocating the piston means (22) such that the piston means (22) impacts the distal end wall (16) on an advancing stroke.
    Type: Grant
    Filed: August 14, 2000
    Date of Patent: December 25, 2001
    Inventors: Thomas Julius Borody, Peter Stephenson, John Begg, Peter Ayre
  • Patent number: 6229270
    Abstract: A high frequency control circuit for a gaseous discharge lamp which includes a mechanically variable reactance device coupled in series with the lamp to control the current fed to the lamp. The mechanically variable reactance device is adjustable by a user to alter the intensity of the light emitted by the lamp.
    Type: Grant
    Filed: January 26, 2000
    Date of Patent: May 8, 2001
    Assignee: InDigitale Limited
    Inventors: John Peter Stephenson, George Alan Limpkin
  • Patent number: 5014565
    Abstract: A variable ratio transmission unit includes at least one first transmission element mounted for rotation about a first axis, and at least one second transmission element in contact with the first element and mounted for rotation about a second axis. The first and second axes define a predetermined angle with each other. The first transmission element is generally disc shaped, with a profiled contact face on one major surface thereof, and the second transmission element is generally cylindrical, with a complementary profiled contact face on its periphery. The second element is slidable axially along the second axis to vary the distance between the point of contact of the elements and the first axis, to vary the effective transmission ratio.
    Type: Grant
    Filed: July 27, 1989
    Date of Patent: May 14, 1991
    Assignees: Peter Stephenson, Jacobus Swanepoel
    Inventor: Peter Stephenson